CD4 and Zika virus infectious disease: These findings highlight that the ZIKV prME mRNA‐PPSNs vaccine candidate induced antigen‐specific CD4+ and CD8+ T cell responses with significant polyfunctionality, underscoring its potential in controlling ZIKV infection.